165 related articles for article (PubMed ID: 22524569)
1. Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective.
Chan SL; Johnson P
Asia Pac J Clin Oncol; 2012 Jun; 8(2):111-4. PubMed ID: 22524569
[No Abstract] [Full Text] [Related]
2. Which treatment modality should we choose for advanced hepatocellular carcinoma?
Kim DY
Korean J Hepatol; 2010 Dec; 16(4):353-4. PubMed ID: 21415577
[No Abstract] [Full Text] [Related]
3. Closing remarks.
Kudo M
Clin Drug Investig; 2012 Aug; 32 Suppl 2():52. PubMed ID: 22873627
[No Abstract] [Full Text] [Related]
4. Major achievements in hepatocellular carcinoma.
Bruix J; Llovet JM
Lancet; 2009 Feb; 373(9664):614-6. PubMed ID: 19231618
[No Abstract] [Full Text] [Related]
5. Sequential therapy of transarterial chemoembolisation and sorafenib in intermediate stage hepatocellular carcinoma.
Welker MW; Zangos S; Kriener S; Mönch C; Zeuzem S; Trojan J
J Gastrointest Cancer; 2010 Jun; 41(2):149-52. PubMed ID: 20396977
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis.
Duan F; Wang MQ; Liu FY; Wang ZJ; Song P; Wang Y
Asia Pac J Clin Oncol; 2012 Jun; 8(2):156-63. PubMed ID: 22524574
[TBL] [Abstract][Full Text] [Related]
7. TACE with or without systemic therapy?
Dufour JF
J Hepatol; 2012 Jun; 56(6):1224-5. PubMed ID: 22402292
[No Abstract] [Full Text] [Related]
8. Regression of hepatocellular carcinoma with right atrial extension after sorafenib and transarterial chemoembolization.
Subramanian M; Singal AG; Yopp AC
Clin Gastroenterol Hepatol; 2012 Oct; 10(10):e83-4. PubMed ID: 22813441
[No Abstract] [Full Text] [Related]
9. Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.
Sinakos E; Dedes I; Papalavrentios L; Drevelegas A; Akriviadis E
Scand J Gastroenterol; 2010 Apr; 45(4):511-2. PubMed ID: 20113152
[No Abstract] [Full Text] [Related]
10. [Clinical observation of the treatment with combination of transcatheter arterial chemoembolization and sorafenib for hepatocellular carcinoma with lung metastasis].
Duan F; Wang MQ; Liu FY; Wang ZJ; Song P
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):716-8. PubMed ID: 20021873
[TBL] [Abstract][Full Text] [Related]
11. Treatment of intermediate-stage hepatocellular carcinoma.
Finn RS
Clin Adv Hematol Oncol; 2015 Aug; 13(8):501-3. PubMed ID: 26351811
[No Abstract] [Full Text] [Related]
12. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of refractory pulmonary metastases from hepatocellular carcinoma by transcatheter arterial chemoembolization using arsenic trioxide in combination with sorafinib].
Hu H; Chen C; Li H
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):942-3. PubMed ID: 26887626
[No Abstract] [Full Text] [Related]
15. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy.
Lencioni R
Crit Rev Oncol Hematol; 2012 Aug; 83(2):216-24. PubMed ID: 22142656
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Geschwind JF; Chapiro J
Clin Adv Hematol Oncol; 2016 Aug; 14(8):585-7. PubMed ID: 27487101
[No Abstract] [Full Text] [Related]
17. The effect of transcatheter arterial chemoembolization on hepatitis C viremia.
Mahale P; Kaseb A; Davila M; Torres HA
Oncologist; 2012; 17(9):e21-3. PubMed ID: 23002170
[TBL] [Abstract][Full Text] [Related]
18. mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantation.
Waidmann O; Hofmann WP; Zeuzem S; Trojan J
J Hepatol; 2011 Feb; 54(2):396-8. PubMed ID: 21111506
[No Abstract] [Full Text] [Related]
19. Contemporary management of hepatocellular carcinoma.
Palmer D
Clin Med (Lond); 2008 Aug; 8(4):442-7. PubMed ID: 18724617
[No Abstract] [Full Text] [Related]
20. [Chemotherapy].
Ikeda M; Nakachi K; Mitsunaga S; Ueno H; Morizane C; Kondo S; Okusaka T
Gan To Kagaku Ryoho; 2010 Mar; 37(3):408-12. PubMed ID: 20332676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]